{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:41:37Z","timestamp":1777603297433,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ther Innov Regul Sci"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s43441-022-00479-w","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T01:10:40Z","timestamp":1669165840000},"page":"476-483","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy and Safety of Ophthalmic Preparations of Glucocorticoids in Patients with Epidemic Keratoconjunctivitis: A Systematic Review and Meta-analysis"],"prefix":"10.1007","volume":"57","author":[{"given":"Pengpeng","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangyao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"MD","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinglin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"MD","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,22]]},"reference":[{"issue":"27","key":"479_CR1","first-page":"475","volume":"108","author":"B Meyer-R\u00fcsenberg","year":"2011","unstructured":"Meyer-R\u00fcsenberg B, Loderst\u00e4dt U, Richard G, et al. Epidemic keratoconjunctivitis: the current situation and recommendations for prevention and treatment. Dtsch Arztebl Int. 2011;108(27):475\u201380.","journal-title":"Dtsch Arztebl Int"},{"issue":"1","key":"479_CR2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1556\/EuJMI.4.2014.1.2","volume":"4","author":"B Ghebremedhin","year":"2014","unstructured":"Ghebremedhin B. Human adenovirus: viral pathogen with increasing importance.  Eur J of Microbial Immuno 1(BP). 2014;4(1):26\u201333.","journal-title":"Eur J of Microbial Immuno 1(BP)"},{"issue":"3","key":"479_CR3","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/MAJ.0b013e3181637417","volume":"336","author":"BL Udeh","year":"2008","unstructured":"Udeh BL, Schneider JE, Ohsfeldt RL. Cost effectiveness of a point-of-care test for adenoviral conjunctivitis.  Am J Med Sci. 2008;336(3):254\u201364.","journal-title":"Am J Med Sci"},{"key":"479_CR4","first-page":"2132","volume":"16","author":"KF Tabbara","year":"2010","unstructured":"Tabbara KF, Omar N, Hammouda E, et al. Molecular epidemiology of adenoviral keratoconjunctivitis in Saudi Arabia.  Mol Vis. 2010;16:2132\u20136.","journal-title":"Mol Vis"},{"key":"479_CR5","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.survophthal.2015.04.001","volume":"60","author":"V Jhanji","year":"2015","unstructured":"Jhanji V, Chan TC, Li EY, et al. Adenoviral keratoconjunctivitis.  Surv Ophthalmol. 2015;60:435\u201343.","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"479_CR6","first-page":"CD013520","volume":"3","author":"SH Liu","year":"2022","unstructured":"Liu SH, Hawkins BS, Ng SM, et al. Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis. Cochrane Database Syst Rev. 2022;3(3):CD013520.","journal-title":"Cochrane Database Syst Rev"},{"key":"479_CR7","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.jfo.2010.07.003","volume":"33","author":"G Renard","year":"2010","unstructured":"Renard G. Adenoviral keratoconjunctivitis. J Fr Ophtalmol. 2010;33:586\u201392.","journal-title":"J Fr Ophtalmol"},{"issue":"4","key":"479_CR8","doi-asserted-by":"publisher","first-page":"408","DOI":"10.4103\/joco.joco_218_20","volume":"33","author":"D Gouider","year":"2022","unstructured":"Gouider D, Khallouli A, Maalej A, et al. Role of anterior segment optical coherence tomography in monitoring epidemic keratoconjunctivitis. J Curr Ophthalmol. 2022;33(4):408\u201312.","journal-title":"J Curr Ophthalmol"},{"issue":"2","key":"479_CR9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/01.ico.0000170693.13326.fb","volume":"25","author":"AL Butt","year":"2006","unstructured":"Butt AL, Chodosh J. Adenoviral keratoconjunctivitis in a tertiary care eye clinic. Cornea. 2006;25(2):199\u2013202.","journal-title":"Cornea"},{"issue":"1","key":"479_CR10","first-page":"140","volume":"126","author":"American Academy of Ophthalmology","year":"2019","unstructured":"American Academy of Ophthalmology. Conjunctivitis Preferred Practice Pattern\u00ae. Ophthalmology. 2019;126(1):140\u201350.","journal-title":"Ophthalmology"},{"issue":"1","key":"479_CR11","first-page":"98","volume":"14","author":"A Rafe","year":"2020","unstructured":"Rafe A, Munawar T, Mansha M, et al. Comparison of topical steroid drops with cyclosporin eye drops in the treatment of corneal subepithelial infiltrates in epidemic keratoconjunctivitis. Pak J Med Health Sci. 2020;14(1):98\u2013100.","journal-title":"Pak J Med Health Sci"},{"key":"479_CR12","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2147\/OPTH.S207976","volume":"14","author":"BA Labib","year":"2020","unstructured":"Labib BA, Minhas BK, Chigbu DI. Management of adenoviral keratoconjunctivitis: challenges and solutions. Clin Ophthalmol. 2020;14:837.","journal-title":"Clin Ophthalmol"},{"key":"479_CR13","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.","journal-title":"BMJ"},{"issue":"9","key":"479_CR14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603\u20135.","journal-title":"Eur J Epidemiol"},{"key":"479_CR15","unstructured":"Higgins JPT, Green S, Higgins J. Cochrane handbook for systematic reviews of interventions (version 5.1.0). The Cochrane Collaboration. 2011. http:\/\/handbook-5-1.cochrane.org\/ Accessed 1 Apr 2021."},{"issue":"6","key":"479_CR16","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1097\/ICO.0000000000002589","volume":"40","author":"D Gouider","year":"2021","unstructured":"Gouider D, Khallouli A, Maalej A, et al. Corticosteroids versus cyclosporine for subepithelial infiltrates secondary to epidemic keratoconjunctivitis: a prospective randomized double-blind study. Cornea. 2021;40(6):726\u201332.","journal-title":"Cornea"},{"issue":"5","key":"479_CR17","doi-asserted-by":"publisher","first-page":"594","DOI":"10.4103\/ijo.IJO_1352_18","volume":"67","author":"R Bhargava","year":"2019","unstructured":"Bhargava R, Kumar P. Comparison of the safety and efficacy of topical Tacrolimus (0.03%) versus dexamethasone (0.05%) for subepithelial infiltrates after adenoviral conjunctivitis. Indian J Ophthalmol. 2019;67(5):594\u20138.","journal-title":"Indian J Ophthalmol"},{"issue":"8","key":"479_CR18","doi-asserted-by":"publisher","first-page":"e686","DOI":"10.1111\/aos.13416","volume":"95","author":"N Kovalyuk","year":"2017","unstructured":"Kovalyuk N, Kaiserman I, Mimouni M, et al. Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0% and dexamethasone 0.1% drops: a clinical prospective controlled randomized study. Acta Ophthalmol. 2017;95(8):e686\u201392.","journal-title":"Acta Ophthalmol"},{"issue":"3","key":"479_CR19","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/00003226-199305000-00006","volume":"12","author":"JB Ward","year":"1993","unstructured":"Ward JB, Siojo LG, Waller SG. A prospective, masked clinical trial of trifluridine, dexamethasone, and artificial tears in the treatment of epidemic keratoconjunctivitis. Cornea. 1993;12(3):216\u201321.","journal-title":"Cornea"},{"issue":"1","key":"479_CR20","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1001\/archopht.1970.00990040038010","volume":"84","author":"PR Laibson","year":"1970","unstructured":"Laibson PR, Dhiri S, Oconer J, et al. Corneal infiltrates in epidemic keratoconjunctivitis. Response to double-blind corticosteroid therapy. Arch Ophthalmol. 1970;84(1):36\u201340.","journal-title":"Arch Ophthalmol"},{"key":"479_CR21","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/eye.2017.4","volume":"31","author":"L Asena","year":"2017","unstructured":"Asena L, \u015e\u0131ngar\u00d6zdemir E, Burcu A, et al. Comparison of clinical outcome with different treatment regimens in acute adenoviral keratoconjunctivitis. Eye (Lond). 2017;31:781\u20137.","journal-title":"Eye (Lond)"},{"issue":"7","key":"479_CR22","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s004170050118","volume":"236","author":"JH Chung","year":"1998","unstructured":"Chung JH, Kang YG, Kim HJ. Effect of 0.1% dexamethasone on epithelial healing in experimental corneal alkali wounds: morphological changes during the repair process. Graefes Arch Clin Exp Ophthalmol. 1998;236(7):537\u201345.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"479_CR23","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0014-4835(87)80003-9","volume":"44","author":"RN Williams","year":"1987","unstructured":"Williams RN, Paterson CA. The influence of topical corticosteroid therapy upon polymorphonuclear leukocyte distribution, vascular integrity and ascorbate levels in endotoxin-induced inflammation of the rabbit eye. Exp Eye Res. 1987;44(2):191\u20138.","journal-title":"Exp Eye Res"},{"issue":"8","key":"479_CR24","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1089\/jop.2021.0040","volume":"37","author":"B Sharma","year":"2021","unstructured":"Sharma B, Soni D, Mohan RR, et al. Corticosteroids in the management of infectious keratitis: a concise review. J Ocul Pharmacol Ther. 2021;37(8):452\u201363.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"2","key":"479_CR25","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1017\/S0022172400064810","volume":"93","author":"S Richmond","year":"1984","unstructured":"Richmond S, Burman R, Crosdale E, et al. A large outbreak of keratoconjunctivitis due to adenovirus type 8. J Hyg (Lond). 1984;93(2):285\u201391.","journal-title":"J Hyg (Lond)"},{"issue":"4","key":"479_CR26","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/aos.12496","volume":"93","author":"SA Kurna","year":"2015","unstructured":"Kurna SA, Altun A, Oflaz A, et al. Evaluation of impact of persistent subepithelial corneal infiltrates on the visual performance and corneal optical quality after epidemic keratoconjunctivitis. Acta Ophthalmol. 2015;93(4):377\u201382.","journal-title":"Acta Ophthalmol"},{"issue":"6","key":"479_CR27","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1097\/00003226-200108000-00020","volume":"20","author":"EG Romanowski","year":"2001","unstructured":"Romanowski EG, Yates KA, Gordon YJ. Short-term treatment with a potent topical corticosteroid of an acute ocular adenoviral infection in the New Zealand white rabbit. Cornea. 2001;20(6):657\u201360.","journal-title":"Cornea"},{"issue":"1","key":"479_CR28","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1167\/iovs.10-5944","volume":"52","author":"C Clement","year":"2011","unstructured":"Clement C, Capriotti JA, Kumar M, et al. Clinical and antiviral efficacy of an ophthalmic formulation of dexamethasone povidone-iodine in a rabbit model of adenoviral keratoconjunctivitis. Inves Ophthalmol Vis Sci. 2011;52(1):339\u201344.","journal-title":"Inves Ophthalmol Vis Sci"},{"issue":"4","key":"479_CR29","doi-asserted-by":"publisher","first-page":"269","DOI":"10.4103\/tjo.tjo_66_19","volume":"10","author":"C Kulkarni","year":"2019","unstructured":"Kulkarni C, Ballal K. A treatment protocol for minimizing duration and complications of adenoviral epidemic keratoconjunctivitis. Taiwan J Ophthalmol. 2019;10(4):269\u201377.","journal-title":"Taiwan J Ophthalmol"},{"issue":"1","key":"479_CR30","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10384-020-00788-3","volume":"65","author":"K Matsuura","year":"2021","unstructured":"Matsuura K, Terasaka Y, Miyazaki D, et al. Comparative study of topical regimen for adenoviral kearoconjunctivitis by 0.1% fluorometholone with and without polyvinyl alcohol iodine. Jpn J Ophthalmol. 2021;65(1):107\u201314.","journal-title":"Jpn J Ophthalmol"}],"container-title":["Therapeutic Innovation & Regulatory Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-022-00479-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43441-022-00479-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-022-00479-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T13:30:38Z","timestamp":1682515838000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43441-022-00479-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,22]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["479"],"URL":"https:\/\/doi.org\/10.1007\/s43441-022-00479-w","relation":{},"ISSN":["2168-4790","2168-4804"],"issn-type":[{"value":"2168-4790","type":"print"},{"value":"2168-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,22]]},"assertion":[{"value":"12 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}